Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959)

Overview of attention for article published in BMC Medicine, October 2019

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 12,411 followers.

Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959). https://t.co/XEEg9SaJ62 H/T @NCBI #radonc #PubMed

15 Jan 2020

Reply Repost Favourite

Development and validation of a #novel #MR #imaging predictor of response to induction #chemotherapy in #locoregionally advanced #nasopharyngeal #cancer: a randomized controlled trial substudy (NCT01245959). #LANPC #ICT #CCRT #ICTOS https://t.co/33wasW44Zd

29 Oct 2019

Reply Repost Favourite

Published this week in @BMCMedicine: Development and validation of a novel MR imaging predictor of response to induction #chemotherapy in locoregionally advanced nasopharyngeal #cancer: a randomized controlled #trial substudy https://t.co/cLuavo1lKC https:

25 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.